| Nome |
# |
|
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021, file e2188be8-31b1-4564-e053-6605fe0a49d6
|
240
|
|
On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin, file a629afc9-649a-4639-a0a1-6506b61b0de1
|
89
|
|
Crispr/cas9 ablation of integrated hiv-1 accumulates proviral dna circles with reformed long terminal repeats, file e2188be8-0f50-4564-e053-6605fe0a49d6
|
76
|
|
Redondovirus DNA in human respiratory samples, file e2188be7-8a35-4564-e053-6605fe0a49d6
|
57
|
|
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19, file e2188be7-d4f7-4564-e053-6605fe0a49d6
|
46
|
|
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence, file e2188be8-2c2c-4564-e053-6605fe0a49d6
|
44
|
|
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine, file 0ad152cb-b7e3-40ad-ab7d-ab8a0f9ccda2
|
40
|
|
Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases, file 495e0c38-934d-47c4-838b-b5b4fe661fa2
|
33
|
|
Analysis of immune escape variants from antibody‐based therapeutics against covid‐19: A systematic review, file e2188be8-0f52-4564-e053-6605fe0a49d6
|
31
|
|
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022, file 2bde50ae-396e-4b7f-9260-7fc9c7fca19b
|
28
|
|
Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy, file e2188be7-8a3c-4564-e053-6605fe0a49d6
|
26
|
|
Hyaluronan: A neuroimmune modulator in the microbiota-gut axis, file e2188be8-13c7-4564-e053-6605fe0a49d6
|
26
|
|
A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY, file e2188be8-0cf4-4564-e053-6605fe0a49d6
|
25
|
|
Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection, file e2188be8-2326-4564-e053-6605fe0a49d6
|
24
|
|
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients, file fb792f4c-9b77-477d-b0d3-ff59cb96b8aa
|
24
|
|
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children, file 32b51339-5d3c-469f-9f4d-a6cc0f078c34
|
22
|
|
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?, file e2188be8-0c95-4564-e053-6605fe0a49d6
|
20
|
|
Delivery Mode Shapes the Composition of the Lower Airways Microbiota in Newborns, file e2188be8-2f32-4564-e053-6605fe0a49d6
|
19
|
|
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation, file e2188be8-225b-4564-e053-6605fe0a49d6
|
18
|
|
Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?, file e2188be8-2827-4564-e053-6605fe0a49d6
|
17
|
|
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study, file e2188be8-2d51-4564-e053-6605fe0a49d6
|
17
|
|
Detection of Torquetenovirus and Redondovirus DNA in Saliva Samples from SARS-CoV-2-Positive and -Negative Subjects, file f6edf0e8-4475-4473-a939-6b89f3ce7a50
|
14
|
|
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021, file e2188be7-d826-4564-e053-6605fe0a49d6
|
13
|
|
Safety and immunogenicity of synchronous COVID19 and influenza vaccination, file e2188be8-38f3-4564-e053-6605fe0a49d6
|
13
|
|
COVID-19 emergency management: From the reorganization of the endoscopy service to the verification of the reprocessing efficacy, file e2188be7-8a33-4564-e053-6605fe0a49d6
|
12
|
|
Asymptomatic SARS-CoV-2 vaccine breakthrough infections in health care workers identified through routine universal surveillance testing, file e2188be7-f923-4564-e053-6605fe0a49d6
|
12
|
|
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy, file e2188be7-d484-4564-e053-6605fe0a49d6
|
11
|
|
Performance Assessment of the LIAISON® SARS-CoV-2 Antigen Assay On Nasopharyngeal Swabs, file e2188be8-11eb-4564-e053-6605fe0a49d6
|
11
|
|
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy, file 2ae491c4-369d-47dd-8ed1-cb558b6bfbb1
|
10
|
|
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy, file e2188be7-e3b2-4564-e053-6605fe0a49d6
|
10
|
|
How multiplex testing approach to respiratory viruses detection can enhance influenza surveillance, file e2188be7-f22a-4564-e053-6605fe0a49d6
|
10
|
|
TTV GUIDE IT - A randomised controlled trial to compare the safety, tolerability and preliminary efficacy between standard and torque teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation - a trial protocol, file e2188be8-1224-4564-e053-6605fe0a49d6
|
8
|
|
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody, file e2188be7-cfba-4564-e053-6605fe0a49d6
|
7
|
|
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy, file e2188be7-d0d8-4564-e053-6605fe0a49d6
|
7
|
|
Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer, file e2188be7-d13f-4564-e053-6605fe0a49d6
|
7
|
|
SPIKE PROTEIN EVOLUTION IN THE SARS-CoV-2 DELTA VARIANT OF CONCERN: A CASE SERIES FROM NORTHERN LOMBARDY, file e2188be7-edaf-4564-e053-6605fe0a49d6
|
7
|
|
COVID-19 and smoking: Is nicotine the hidden link?, file e2188be7-8a37-4564-e053-6605fe0a49d6
|
6
|
|
SYMPTOMATIC SARS-CoV-2 INFECTIONS AFTER FULL SCHEDULE BNT162b2 VACCINATION IN SEROPOSITIVE HEALTHCARE WORKERS: A CASE SERIES FROM A SINGLE INSTITUTION, file e2188be7-d4ab-4564-e053-6605fe0a49d6
|
6
|
|
TTV viral load as a predictor of antibody response to SARS COV-2 vaccination, file 9174925c-2029-4858-97d1-6c0b3e7948b8
|
5
|
|
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus (TTV) viremia, the new surrogate marker of immune competence, file e2188be7-80e3-4564-e053-6605fe0a49d6
|
5
|
|
Small anellovirus in hepatitis C patients and healthy controls, file e2188be7-8261-4564-e053-6605fe0a49d6
|
4
|
|
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline, file e2188be7-9438-4564-e053-6605fe0a49d6
|
4
|
|
Impact of Microbial Metabolites on Microbiota–Gut–Brain Ax-is in Inflammatory Bowel Disease, file e2188be7-cb31-4564-e053-6605fe0a49d6
|
4
|
|
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy, file e2188be7-cd8d-4564-e053-6605fe0a49d6
|
4
|
|
Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity, file e2188be7-8bc8-4564-e053-6605fe0a49d6
|
3
|
|
Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats, file e2188be7-9145-4564-e053-6605fe0a49d6
|
3
|
|
Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy, file e2188be7-cbdf-4564-e053-6605fe0a49d6
|
3
|
|
Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin, file e2188be7-cc1c-4564-e053-6605fe0a49d6
|
3
|
|
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients, file e2188be7-cd88-4564-e053-6605fe0a49d6
|
3
|
|
Is a single COVID-19 vaccine dose enough in convalescents ?, file e2188be7-ce66-4564-e053-6605fe0a49d6
|
3
|
|
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes, file e2188be7-cfbb-4564-e053-6605fe0a49d6
|
3
|
|
The effect of SARS-CoV-2 variants on the plasma oxylipins and PUFAs of COVID-19 patients, file 91cdb9b2-a126-446f-9b6a-09b648694d26
|
2
|
|
The role of bone marrow cells for JCV pathogenicity, file e2188be7-7c4c-4564-e053-6605fe0a49d6
|
2
|
|
Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens, file e2188be7-8425-4564-e053-6605fe0a49d6
|
2
|
|
Taxonomic updates for the genus Gyrovirus (family Anelloviridae): recognition of several new members and establishment of species demarcation criteria, file e2188be8-0e71-4564-e053-6605fe0a49d6
|
2
|
|
Taxonomic update for mammalian anelloviruses (family Anelloviridae), file e2188be8-0f58-4564-e053-6605fe0a49d6
|
2
|
|
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: A prospective observational study, file e2188be8-2c34-4564-e053-6605fe0a49d6
|
2
|
|
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022, file 8d8793f3-43e6-45eb-8576-8da54ad802ae
|
1
|
|
Torquetenovirus: the human virome from bench to bedside, file e2188be7-8278-4564-e053-6605fe0a49d6
|
1
|
|
JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis, file e2188be7-82e4-4564-e053-6605fe0a49d6
|
1
|
|
JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis, file e2188be7-82e5-4564-e053-6605fe0a49d6
|
1
|
|
Filovirus, file e2188be7-842c-4564-e053-6605fe0a49d6
|
1
|
|
Filovirus, file e2188be7-8435-4564-e053-6605fe0a49d6
|
1
|
|
JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis, file e2188be7-8e2d-4564-e053-6605fe0a49d6
|
1
|
|
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients, file e2188be7-cd8b-4564-e053-6605fe0a49d6
|
1
|
|
Molecular validation of pathogen-reduction technologies using rolling-circle amplification coupled with real-time PCR for torquetenovirus DNA quantification, file e2188be8-0f56-4564-e053-6605fe0a49d6
|
1
|
|
COVID-19 infodemics: the role of mainstream and social media, file e2188be8-1071-4564-e053-6605fe0a49d6
|
1
|
|
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic, file e2188be8-2c2e-4564-e053-6605fe0a49d6
|
1
|
|
Is SARS-CoV-2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody-based therapeutics?, file e2188be8-2d4f-4564-e053-6605fe0a49d6
|
1
|
|
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis, file e2188be8-2f30-4564-e053-6605fe0a49d6
|
1
|
|
MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation, file e2188be8-328b-4564-e053-6605fe0a49d6
|
1
|
| Totale |
1.159 |